Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D M Nanus

Showing results (41-50 of 64) with videos related to

Pageof 7
Sort By:
Anticancer Research|March 1, 1996
Expression of the retinoblastoma gene product in renal tumorsJ C Presti, V E Reuter, C Cordon-Cardo, et al.
The Journal of Experimental Medicine|March 1, 1989
Transformation of human kidney proximal tubule cells by ras-containing retroviruses. Implications for tumor progressionD M Nanus, S A Ebrahim, N H Bander, et al.
Investigational New Drugs|January 1, 1997
A phase II study of 13-cis-retinoic acid in patients with advanced renal cell carcinomaW J Berg, L H Schwartz, A Amsterdam, et al.
Prostate Cancer and Prostatic Diseases|June 15, 2007
Neutral endopeptidase inhibits prostate cancer tumorigenesis by reducing FGF-2-mediated angiogenesisA Horiguchi, D Y T Chen, O B Goodman, et al.
The Journal of Thoracic and Cardiovascular Surgery|November 11, 1992
Ras oncogene point mutation: an infrequent event in bronchioloalveolar cancerV W Rusch, V E Reuter, M G Kris, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1995
Interferon alfa-2a and 13-cis-retinoic acid in renal cell carcinoma: antitumor activity in a phase II trial and interactions in vitroR J Motzer, L Schwartz, T M Law, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2000
Methylation of the neutral endopeptidase gene promoter in human prostate cancersB A Usmani, R Shen, M Janeczko, et al.
Anticancer Research|May 6, 1998
Expression of the kidney-associated differentiation glycoprotein gp160 and resistance to the antitumor effects of interferon alpha in renal cell carcinomasY Geng, A Biffi, D Engelstein, et al.
British Journal of Cancer|June 10, 2004
Downregulation of Bcl-2 sensitises interferon-resistant renal cancer cells to FasJ D Kelly, J Dai, P Eschwege, et al.
International Journal of Cancer|August 19, 1993
Interleukin-10 production by human carcinoma cell lines and its relationship to interleukin-6 expressionG A Gastl, J S Abrams, D M Nanus, et al.
Pageof 7

Showing results (41-50 of 64) with videos related to

Sort By:
Pageof 7
Anticancer Research|March 1, 1996
Expression of the retinoblastoma gene product in renal tumorsJ C Presti, V E Reuter, C Cordon-Cardo, et al.
The Journal of Experimental Medicine|March 1, 1989
Transformation of human kidney proximal tubule cells by ras-containing retroviruses. Implications for tumor progressionD M Nanus, S A Ebrahim, N H Bander, et al.
Investigational New Drugs|January 1, 1997
A phase II study of 13-cis-retinoic acid in patients with advanced renal cell carcinomaW J Berg, L H Schwartz, A Amsterdam, et al.
Prostate Cancer and Prostatic Diseases|June 15, 2007
Neutral endopeptidase inhibits prostate cancer tumorigenesis by reducing FGF-2-mediated angiogenesisA Horiguchi, D Y T Chen, O B Goodman, et al.
The Journal of Thoracic and Cardiovascular Surgery|November 11, 1992
Ras oncogene point mutation: an infrequent event in bronchioloalveolar cancerV W Rusch, V E Reuter, M G Kris, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1995
Interferon alfa-2a and 13-cis-retinoic acid in renal cell carcinoma: antitumor activity in a phase II trial and interactions in vitroR J Motzer, L Schwartz, T M Law, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2000
Methylation of the neutral endopeptidase gene promoter in human prostate cancersB A Usmani, R Shen, M Janeczko, et al.
Anticancer Research|May 6, 1998
Expression of the kidney-associated differentiation glycoprotein gp160 and resistance to the antitumor effects of interferon alpha in renal cell carcinomasY Geng, A Biffi, D Engelstein, et al.
British Journal of Cancer|June 10, 2004
Downregulation of Bcl-2 sensitises interferon-resistant renal cancer cells to FasJ D Kelly, J Dai, P Eschwege, et al.
International Journal of Cancer|August 19, 1993
Interleukin-10 production by human carcinoma cell lines and its relationship to interleukin-6 expressionG A Gastl, J S Abrams, D M Nanus, et al.
Pageof 7